|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| CURRENT ASSETS: | |||||||||
| Cash and cash equivalents | |||||||||
| Marketable securities | |||||||||
| Receivable from former parent | |||||||||
| Prepaid expenses | |||||||||
| Restricted cash | |||||||||
| Other current assets | |||||||||
| Total current assets | |||||||||
| Property and equipment, net | |||||||||
| Right-of-use assets | |||||||||
| Restricted cash | |||||||||
| Other assets | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| CURRENT LIABILITIES: | |||||||||
| Accounts payable | |||||||||
| Accrued expenses | |||||||||
| Operating lease liabilities-short-term | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Operating lease liabilities-long-term | |||||||||
| Other liabilities | |||||||||
| Total liabilities | |||||||||
| Net parent investment | |||||||||
| Preferred shares, nominal value $0.01; 50,000,000 shares authorized at September 30, 2025 and December 31, 2024; no shares issued or outstanding at September 30, 2025 or December 31, 2024 | |||||||||
| Ordinary shares, nominal value $0.01; 450,000,000 ordinary shares authorized at September 30, 2025 and December 31, 2024; 17,324,771 and 17,095,371 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Unrealized gain on marketable securities | |||||||||
| Accumulated deficit | |||||||||
| Total equity | |||||||||
| TOTAL LIABILITIES AND EQUITY |
Loading...
